Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease.

Armstrong PJ, Johanning JM, Calton WC Jr, Delatore JR, Franklin DP, Han DC, Carey DJ, Elmore JR.

J Vasc Surg. 2002 Feb;35(2):346-55.

2.
3.

Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease.

Absi TS, Sundt TM 3rd, Tung WS, Moon M, Lee JK, Damiano RR Jr, Thompson RW.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):344-57; discission 357.

4.

Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.

Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, Yao JS, Pearce WH.

J Vasc Surg. 1994 Nov;20(5):774-84; discussion 784-6.

PMID:
7966813
5.

TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas.

Defawe OD, Colige A, Lambert CA, Munaut C, Delvenne P, Lapière CM, Limet R, Nusgens BV, Sakalihasan N.

Cardiovasc Res. 2003 Oct 15;60(1):205-13.

7.

Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease.

Biros E, Gäbel G, Moran CS, Schreurs C, Lindeman JH, Walker PJ, Nataatmadja M, West M, Holdt LM, Hinterseher I, Pilarsky C, Golledge J.

Oncotarget. 2015 May 30;6(15):12984-96.

8.

Aneurysm or occlusive disease--factors determining the clinical course of atherosclerosis of the infrarenal aorta.

McGee GS, Baxter BT, Shively VP, Chisholm R, McCarthy WJ, Flinn WR, Yao JS, Pearce WH.

Surgery. 1991 Aug;110(2):370-5; discussion 375-6.

PMID:
1858045
9.
10.

Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.

Yamashita A, Noma T, Nakazawa A, Saito S, Fujioka K, Zempo N, Esato K.

World J Surg. 2001 Mar;25(3):259-65.

PMID:
11343173
11.

Identification and characterization of microRNAs in vascular smooth muscle cells from patients with abdominal aortic aneurysms.

Cheuk BL, Cheng SW.

J Vasc Surg. 2014 Jan;59(1):202-9. doi: 10.1016/j.jvs.2013.02.244. Epub 2013 Jun 5.

12.

Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.

Tamarina NA, McMillan WD, Shively VP, Pearce WH.

Surgery. 1997 Aug;122(2):264-71; discussion 271-2.

PMID:
9288131
13.

Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases.

Knox JB, Sukhova GK, Whittemore AD, Libby P.

Circulation. 1997 Jan 7;95(1):205-12.

14.

Differential expression of immunoglobulin kappa chain constant region in human abdominal aortic aneurysm.

Kim DI, Eo HS, Joh JH.

J Surg Res. 2005 Aug;127(2):118-22. Epub 2005 Apr 14.

PMID:
16083750
15.
16.

In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta.

McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH.

Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1139-44.

17.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

18.

Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms.

McMillan WD, Pearce WH.

J Vasc Surg. 1999 Jan;29(1):122-7; discussion 127-9.

PMID:
9882796
19.

Cytokine pattern in aneurysmal and occlusive disease of the aorta.

Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, Baxter BT.

J Surg Res. 2001 Dec;101(2):152-6.

PMID:
11735270
20.

Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.

Shireman PK, McCarthy WJ, Pearce WH, Shively VP, Cipollone M, Kwaan HC.

J Vasc Surg. 1997 Jan;25(1):157-64.

Supplemental Content

Support Center